Printer Friendly

CONMED ANNOUNCES NEW PRODUCT

 CONMED ANNOUNCES NEW PRODUCT
 UTICA, N.Y., Oct. 20 /PRNewswire/ -- CONMED Corporation


(NASDAQ: CNMD) today announced that it has received marketing clearance by the Food and Drug Administration (F.D.A.) to market its TroGard(R) Electronic Trocar System for minimally invasive surgical procedures.
 The TroGard Electronic Trocar System is used by surgeons to make the punctures in the bodywall required by minimal access surgery and has been designed to provide surgeons with a new level of safety and reliability in endoscopic trocars. By using electronically controlled electrosurgical current applied through a specially designed blunt trocar tip, TroGard requires less surgical force to penetrate the body wall. Then, the Electronic Trocar Monitor disables the electrosurgical current immediately as the trocar tip enters the body cavity, thus protecting underlying structures. This gives the surgeon greater control over trocar entry.
 Eugene R. Corasanti, chairman of the board and president said, "We have been conducting clinical trials of the TroGard Electronic Trocar for some time. With the marketing clearance from the F.D.A., we will complete the scheduled clinicals and hope to have full market release in the beginning of 1993. We do not presently believe that the Electronic Trocar will have any significant contribution to sales for 1992, however we look forward to gaining market penetration in 1993 and beyond."
 CONMED is a manufacturer of electrosurgery and other medical products used primarily in hospital operating rooms and other critical care areas. The company distributes its products worldwide from manufacturing and warehousing facilities in Utica, N.Y., and Denver.
 -0- 10/20/92
 /CONTACT: Robert D. Shallish of CONMED Corporation, 315-797-8375, ext. 2219/
 (CNMD) CO: CONMED Corporation ST: New York IN: MTC SU: PDT


BM -- CL020 -- 2378 10/20/92 14:04 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 20, 1992
Words:291
Previous Article:PHARMACONTROL REPORTS RESULTS
Next Article:BELLSOUTH REPORTS THIRD QUARTER RESULTS
Topics:


Related Articles
CONMED ANNOUNCES EARNINGS ESTIMATE
CONMED CORPORATION ANNOUNCES F.D.A. MARKETING PERMISSION FOR MODULAR INSTRUMENT SYSTEM
CONMED COMMENCES SELLING NEW STATE-OF-THE-ART PRODUCTS
CONMED COMMENCES SELLING NEW STATE-OF-THE-ART PRODUCTS
CONMED ANNOUNCES EARNINGS ESTIMATE
CONMED ANNOUNCES FIRST QUARTER 1993 EARNINGS
EVEREST MEDICAL SIGNS PRODUCT SUPPLY AGREEMENT WITH CONMED
CONMED EARNINGS PER SHARE IMPROVES 145 PERCENT
CONMED CORPORATION DECLARES A 3 FOR 2 STOCK SPLIT IN THE FORM OF A COMMON STOCK DIVIDEND
CONMED CORPORATION DECLARES A 3 FOR 2 STOCK SPLIT IN THE FORM OF A COMMON STOCK DIVIDEND

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters